+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VINEETLAB

Vineet Laboratories Share Price

₹37.02 +1.23 (3.44%)
32.40% Gain from 52W Low

11 Sep, 2026 3:31 PM (IST)

Vineet Laboratories live price: ₹37.02. It opened at ₹37 vs previous close ₹36; intraday high/low: ₹38/₹35. The 50 & 200 DMA stand at ₹37.10/₹35.20.

Vineet Laboratories Performance

  • Today's Low
  • ₹35
  • Today's High
  • ₹38
  • 52 Week Low
  • ₹28
  • 52 Week High
  • ₹44
  • Open Price₹37
  • Previous Close₹36
  • Volume76,395
  • 50 DMA₹37.10
  • 100 DMA₹36.20
  • 200 DMA₹35.20

Vineet Laboratories Chart

Investment Returns

  • Over 1 Month -1.1%
  • Over 3 Month + 7.3%
  • Over 6 Month + 22.14%
  • Over 1 Year + 29.4%

Smart Investing Starts Here Start SIP with Vineet Laboratories for Steady Growth!

Invest Now

Vineet Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 64
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 71
  • P/B Ratio
  • 2.8
  • Average True Range
  • 2
  • EPS
  • 0.6
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.2
  • RSI
  • 47.22
  • MFI
  • 44.89

Latest Stock News Updates

Vineet Laboratories Ltd - 543298 - Results-Delay in Financial Results

Updated Financial Results for the Quarter and Finacial year ended 31st March 2026

Vineet Laboratories Ltd - 543298 - Results-Delay in Financial Results

The Board of Director of the company in its meeting held on August 25 2026 Approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31st march 2026and the audited Standalone Financial Statement for the financial year ended 31st March 2026 along with audit report

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, August 25, 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

The Board of Directors of the company in its meeting held today i.e., on August 25, 2026 has: Approved the Audited Standalone Financial Results of the Company for the fourth quarter and the financial year ended on 31 March, 2026 and the Audited Standalone Financial Statement for the financial year ended on 31* March 2026 along with Audit Report.

Vineet Laboratories Financials

Vineet Laboratories Technicals

EMA & SMA

Current Price
₹37.02
+ 1.23 (3.44%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹37.50
  • 50 Day
  • ₹37.10
  • 100 Day
  • ₹36.20
  • 200 Day
  • ₹35.20

Resistance and Support

36.54 Pivot Speed
  • R3 40.60
  • R2 39.10
  • R1 38.10
  • S1 35.50
  • S2 34.00
  • S3 32.90

Vineet Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-25 Audited Results To consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31, 2026.
2026-02-14 Quarterly Results
2025-11-27 Right issue of Equity Shares
2025-11-08 Quarterly Results
2025-07-22 Quarterly Results
Date Purpose Remarks
2022-09-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Vineet Laboratories Dividend History Arrow

Vineet Laboratories Shareholding Pattern

93.52%
5.98%
0.5%
0%

Vineet Laboratories FAQs

Vineet Laboratories share price is ₹37 As on 12 September, 2026 | 19:31

The Market Cap of Vineet Laboratories is ₹71.1 Cr As on 12 September, 2026 | 19:31

The P/E ratio of Vineet Laboratories is 64 As on 12 September, 2026 | 19:31

The PB ratio of Vineet Laboratories is 2.8 As on 12 September, 2026 | 19:31

The 52 week High & Low of Vineet Laboratories is ₹43.5/₹28 respectively As on 12 September, 2026 | 19:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23